Dr Gregory Amos heads the Microbiome Section at NIBSC. Greg has a longstanding interest in studying microbial interactions and harnessing microbes for the benefit of humankind. At NIBSC he leads a team of experienced scientists and students who are trying to understand how current microbiome therapeutics work, how the microbiome can cause disease, and how we can exploit the microbiome to deliver novel therapeutics. The team also lead an extensive standardization program to generate the first World Health Organization reference reagents for the microbiome to try and solve the reproducibility crisis in the microbiome field.
Prior to his appointment at NIBSC in 2016, Greg researched the discovery of natural products in the marine environment at The Scripps Institution of Oceanography at The University of California, San Diego. He also worked as a postdoctoral scholar at The University of Warwick studying global hotspots for natural products by developing novel assays for their detection. For his PhD, conducted at Warwick University, Greg helped set up a large collaboration between Warwick, Exeter, and the UK Centre for Ecology and Hydrology which produced several of the first publications describing the evolution and dissemination of antimicrobial resistance (AMR) in the wider UK environment. Greg still has an active interest in AMR and natural products and has integrated these themes into his research programmes at NIBSC.
Greg plays an active role in the UK and international microbiome community. He frequently presents at conferences and policy forums, is an Associate Editor for the journal ‘Microbiome’, and is a member of several committees and special interest groups. He is always interested to hear from people interested in the work of the NIBSC Microbiome Section and is open to new collaborations.
Principal Scientist, Section Head: Microbiome
MicrobiomeAMRNatural ProductsPathogen/Gene detection